Ovarian cancer is the commonest cause of death from a gynaecological malignancy. Diagnosis of the disease at an early stage is associated with significantly improved survival rate. This suggests that screening may impact on disease mortality. This review addresses the current methods of screening, the ongoing trials and future of screening for ovarian cancer.